Short Adherence Intervention for Viral Re-suppression
NCT03242980 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 928
Last updated 2019-12-17
Summary
In the era of test-and-treat, with anticipated high numbers of patients who will have unsuppressed viral load (VL) due to poor adherence, simple, short and standardized adherence interventions with documented efficacy will be needed. Achieving re-suppression in patients with unsuppressed VL is beneficial for the health of the individual, important to reduce the risk of transmission and has a direct cost implication because patients with sustained unsuppressed VL will ultimately be switched to more expensive 2nd-line regimens.
Information is still largely lacking on how to best address adherence problems among patients with unsuppressed VL. VL monitoring is recognized as a useful tool to reinforce adherence in patients with unsuppressed VL. The Lesotho Guidelines recommend redoing a VL 8-12 weeks after the first enhanced adherence counselling. To date no study has been published clearly demonstrating higher re-suppression rates after enhanced adherence counselling for patients with unsuppressed VL.
This project aims to test an adherence intervention for HIV-positive individuals on first-line ART who have an unsuppressed viral load. A step wedged study will be used to compare the effectiveness of a short, standardized adherence counselling followed by an SMS reminder to the standard of care (≥ 2 unstructured adherence counselling sessions) in terms of viral re-suppression rates and switches to 2nd line ART.
Conditions
- Adherence, Medication
- HIV/AIDS
Interventions
- BEHAVIORAL
-
Structured adherence counseling
Patients will undergo one standardized enhanced adherence counselling session. Counselling guidelines and a brochure were specifically developed to guide the adherence counselling for individuals with unsuppressed VL. All nurses at the health centres will be trained on the counselling prior to the cross-over to the intervention. The brochure was developed by culturally adapted by social scientists and contains only 3 key messages. The brochure will be given to the patient to take home. Four weeks after the adherence counselling session, a SMS will be sent to the patient reminding them to take their ART. The content of the text message will be anonymous to protect disclosure and discussed/agreed upon with the patient during the adherence counselling.
Sponsors & Collaborators
-
SolidarMed
collaborator OTHER -
Ministry of Health, Lesotho
collaborator OTHER_GOV -
University of Basel
collaborator OTHER -
Swiss Tropical & Public Health Institute
lead OTHER
Principal Investigators
-
Tracy R Glass, PhD · Swiss TPH
-
Niklaus Labhardt, MD · Swiss TPH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-05-18
- Primary Completion
- 2019-08-01
- Completion
- 2019-12-01
Countries
- Lesotho
Study Locations
More Related Trials
-
Medication Adherence in Human Immunodeficiency Virus (HIV)
NCT02119390 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique
NCT01910493 ·Status: COMPLETED ·Phase: NA
-
Comparative Effectiveness of Brief HIV Care Counseling
NCT04180280 ·Status: COMPLETED ·Phase: NA
-
Scalable Interventions to Increase PrEP Adherence: Value Affirmation and Future Selves
NCT03278990 ·Status: TERMINATED ·Phase: NA
-
Community Health Worker And MHealth to ImProve Viral Suppression
NCT04562649 ·Status: COMPLETED ·Phase: NA
-
Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals
NCT00870792 ·Status: COMPLETED ·Phase: NA
-
Interventions to Improve HIV Antiretroviral Therapy Adherence
NCT03618511 ·Status: COMPLETED ·Phase: NA
-
Incentives to Promote Medication Adherence Among HIV-Infected Youth
NCT02206906 ·Status: COMPLETED
-
SIRI Checklist: An Integrated Hospital Model to Optimize HIV Prevention in Persons Who Inject Drugs
NCT05480956 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy
NCT00959361 ·Status: COMPLETED ·Phase: NA
-
Supporting Adolescents to Adhere - an Intervention Using Airtime Rewards Allocated by a Prize Drawing
NCT02918838 ·Status: COMPLETED ·Phase: NA
-
Medication Adherence and Outcomes Among Patients in United States With HIV
NCT03995745 ·Status: COMPLETED ·Phase: NA
-
Supportive Therapy for Adherence to ART(STAART)
NCT00212940 ·Status: COMPLETED ·Phase: NA
-
AIMS Study: Improving HIV Treatment Adherence
NCT01429142 ·Status: COMPLETED ·Phase: NA
-
Assessing the Effectiveness and Feasibility of Voluntary Assisted Partner Notification Services
NCT03944395 ·Status: UNKNOWN ·Phase: NA
-
A Pilot Study to Examine Efficacy of Peer Mentoring in Promoting Medication Adherence Among People Living With HIV/AIDS
NCT02025322 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness & Implementation of a Behavioral Intervention for Adherence and Substance Use in HIV Care in South Africa
NCT03529409 ·Status: COMPLETED ·Phase: NA
-
Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients
NCT04201288 ·Status: COMPLETED ·Phase: NA
-
Financial Incentives, Randomization With Stepped Treatment Trial
NCT03089320 ·Status: COMPLETED ·Phase: NA
-
Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments
NCT05110963 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Duo Partnership Adherence Commitment Therapy
NCT02925949 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Tailored Virtual Intervention to Empower Persons Living With HIV for Therapy Self-management
NCT01510340 ·Status: COMPLETED ·Phase: PHASE3
-
Minority AIDS Initiative Retention and Re-Engagement Project
NCT01616940 ·Status: COMPLETED ·Phase: NA
-
Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency Virus
NCT01760759 ·Status: COMPLETED ·Phase: NA
-
Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention
NCT06550804 ·Status: RECRUITING ·Phase: PHASE3